Browse > Article

Genetic Toxicity Test of Emodin by Ames, Micronucleus, Comet Assays and Microarray Analysis Showing Differential Result  

Go, Seo-Y. (College of Pharmacy, Ewha Womans University)
Kwon, Kyoung-J. (College of Pharmacy, Ewha Womans University)
Park, Sue-N. (Department of Toxicological Researches, National Institute of Toxicological Research, Korea Food and Drug Administration)
Sheen, Yhun-Y. (College of Pharmacy, Ewha Womans University)
Publication Information
Biomolecules & Therapeutics / v.15, no.3, 2007 , pp. 192-198 More about this Journal
Emodin (1,3,8-trihydroxy-6-methylanthraquinone) is a major constituent of rhubarb. Although it has been claimed to have a wild spectrum of therapeutic value, its side effects, especially in human kidney cells have not been well characterized. In this study, we have carried out in vitro genetic toxicity test of emodin and microarray analysis of differentially expressed genes in response to emodin. The result of Ames test showed mutations with emodin treatment in base substitution strain TA1535 both with and without exogenous metabolic activation. Likewise, emodin showed mutations in frame shift TA98 both with and without exogenous metabolic activation. The result of COMET assay in L5178Y cells with emodin treatment showed DNA damage both with and without exogenous metabolic activation. Emodin did not increase micronuclei in CHO cells both with and without exogenous metabolic activation. 150 Genes were selected as differentially expressed genes in response to emodin by microarray analysis and these genes would be candidate biomarkers of genetic toxic action of emodin.
Emodin; Ames test; COMET assay; MN assay; Microarray; S9 fraction;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Bruggeman I.M. and van der Hoeven J.C. (1984). Lack of activity of the bacterial mutagen emodin in HGPRT and SCE assay with V79 Chinese hamster cells. Mutat Res 138(2-3), 219-224   DOI   ScienceOn
2 Kumar A., Dhawan S. Aggarwal B. B. (1998). Emodin (3-methyl-1,6,8-trihydroxy anthraquinone) inhibits TNF-induced NF-kappaB activation, IkappaB degradation, and expression of cell surface adhesion proteins in human vascular endothelial cells. Oncogene 20, 17, 913-918
3 Affymetrix, Inc. 2000. '$GeneChip^{\circledR}$ Expression Analysis Technical Manual' /manual/expression_manual.affx
4 Kasamatsu T., Ogura R., Ikeda N., Morita O., Saigo K., Watabe H., Saito Y. and Suzuki H. (2005). Genotoxicity studies on dietary diacylglycerol (DAG) oil. Food Chem. Toxicol. 43, 253-260   DOI   ScienceOn
5 Barnard D. L., Huffman J. H., Morris J. L., Wood S. G., Hughes B. G. and Sidwell R.W. (1992). Evaluation of the antiviral activity of anthraquinones, anthrones and anthraquinone derivatives against human cytomegalovirus. Antiviral Res. 17, 63-77
6 Bosch R., Friederich U., Lutz W. K., Brocker E., Bachmann M. and Schlatter C. (1987). Investigations on DNA binding in rat liver and in Salmonella and on mutagenicity in the Ames test by emodin, a natural anthraquinone. Mutat. Res. 188, 161-168   DOI   ScienceOn
7 Gatehouse D., Haworth S., Cebula T., Gocke E., Kier L., Matsushima T., Melcion C., Nohmi T., Venitt S. and Zeiger E. (1994). Recommendations for the performance of bacterial mutation assays. Mutat. Res. 312, 217-233   DOI   ScienceOn
8 Kirsch-Volders M., Sofuni T., Aardema M., Albertini S., Eastmond D., Fenech M., Ishidate M., Kirchner S., Lorge E., Morita T., Norppa H., Surralles J., Vanhauwaert A. and Wakata A. (2003). Report from the in vitro micronucleus assay working group. Mutat. Res. 540, 153-163   DOI   ScienceOn
9 Kodama M., Kamioka Y., Nakayama T., Nagata C., Morooka N. and Ueno Y. (1987). Generation of free radical and hydrogen peroxide from 2-hydroxyemodin, a direct-acting mutagen, and DNA strand breaks by active oxygen. Toxicol. Lett. 37, 149-156   DOI   ScienceOn
10 Krivobok S., Seigle-Murandi F., Steiman R., Marzin D. R. and Betina V. (1992). Mutagenicity of substituted anthraquinones in the Ames/Salmonella microsome system. Mutat. Res. 279, 1-8   DOI   ScienceOn
11 Kuo Y. C., Meng H. C. and Tsai W. J. (2001). Regulation of cell proliferation, inflammatory cytokine production and calcium mobilization in primary human T lymphocytes by emodin from Polygonum hypoleucum Ohwi. Inflamm Res 50, 73-82   DOI
12 Kuo Y. C., Sun C. M., Ou J. C. and Tsai W.J. (1997). A tumor cell growth inhibitor from Polygonum hypoleucum Ohwi. Life Sci. 61, 2335-2344   DOI   ScienceOn
13 Masuda T., Haraikawa K., Morooka N. and Nakano S., (1985). Ueno Y. 2-Hydroxyemodin, an active metabolite of emodin in the hepatic microsomes of rats. Mutat. Res. 149, 327-332   DOI   ScienceOn
14 Masuda T. and Ueno Y. (1984). Microsomal transformation of emodin into a direct mutagen. Mutat. Res. 125, 135-144   DOI   ScienceOn
15 Mengs U., Krumbiegel G. and Volkner W. (1997). Lack of emodin genotoxicity in the mouse micronucleus assay. Mutat. Res. 393, 289-293   DOI   ScienceOn
16 Merck. 1998. The Merck Index Online. Dialog file 304. Emodin
17 Mueller S. O., Lutz W. K., (1998). Stopper H. Factors affecting the genotoxic potency ranking of natural anthraquinones in mammalian cell culture systems. Mutat. Res. 414, 125-129   DOI   ScienceOn
18 Murakami H., Kobayashi J., Masuda T., Morooka N. and Ueno Y. (1987). omega-Hydroxyemodin, a major hepatic metabolite of emodin in various animals and its mutagenic activity. Mutat. Res. 180, 147-153   DOI   ScienceOn
19 Mueller S. O., Stopper H. (1999). Characterization of the genotoxicity of anthraquinones in mammalian cells. Biochim. Biophys. Acta. 1428, 406-414   DOI   ScienceOn
20 Muller S. O., Eckert I., Lutz W. K. and Stopper H. (1996). Genotoxicity of the laxative drug components emodin, aloe-emodin and danthron in mammalian cells: Topoisomerase II mediated? Mutat. Res. 371, 165-173   DOI   ScienceOn
21 Brusick D. and Mengs U. (1997). Assessment of the genotoxic risk from laxative senna products. Environ. Mol. Mutagen. 29, 1-9   DOI   ScienceOn
22 Fenech M. (2000). The in vitro micronucleus technique. Mutat. Res 455, 81-95   DOI   ScienceOn
23 Singh N.T., McCoy M.T., Tice R.R. and Schneider E.L. (1988). A simple technique for quantification of low levels of DNA damage in individual cells. Exp. Cell. Res. 175, 184-191   DOI   ScienceOn
24 von Wright A., Raatikainen O., Taipale H., Karenlampi S. and Mäki-Paakanen J. (1992). Directly acting geno-and cytotoxic agents from a wild mushroom Dermocybe sanguinea. Mutat. Res. 269, 27-33   DOI   ScienceOn
25 Wehner F. C., Thiel P. G. and du Rand M. (1979). Mutagenicity of the mycotoxin emodin in the salmonella/microsome system. Appl. Environ. Microbiol. 37, 658-660
26 Yeh S. F., Chou T. C. and Liu T. S. (1988). Effects of anthraquinones of Polygonum cuspidatum on HL-60 cells. Planta Med. 54, 413-414   DOI   ScienceOn
27 Maclean W., Townsend P. Rhubarb (Da Huang): Rheum palmatum. Accessed on June 7, 1999
28 Zhang L. and Hung M. C. (1996). Sensitization of HER-2/neuoverexpressing non-small cell lung cancer cells to chemotherapeutic drugs by tyrosine kinase inhibitor emodin. Oncogene Feb 1; 12, 571-576
29 Lee H. Z. (2001). Effects and mechanisms of emodin on cell death in human lung squamous cell carcinoma. Br. J. Pharmacol. 134, 11-20   DOI   ScienceOn
30 Liu Z. H., Li L. S., Hu W. X. and Zhou H. (1996). Effect of emodin on c-myc proto-oncongen expression in cultured rat mesan-gial cells. Zhongguo Yao Li Xue Bao 17, 61-63
31 National Toxicology Program, 2001. NTP toxicology and carcinogenesis studies of emodin (CAS NO. 518-82-1) feed studies in F344/N rats and B6C3F1 mice. Natl Toxicol. Program Tech. Rep. Ser. 493, 1-278
32 National Toxicology Program. 2003. Report and study status database: Emodin (CAS No. 518-82-1). National Toxicology Program Home-page, Accessed February 12, 2003
33 Sato M., Maulik G., Bagchi D. and Das D.K. (2000). Myocardial protection by protykin, a novel extract of trans-resveratrol and emodin. Free Radic. Res. 32, 135-144   DOI   ScienceOn
34 Zhang L., Lau Y. K., Xia W., Hortobagyi G. N. and Hung M. C. (1999). Tyrosine kinase inhibitor emodin suppresses growth of HER-2/neu-overexpressing breast cancer cells in athymic mice and sensitizes these cells to the inhibitory effect of paclitaxel. Clin. Cancer Res. 5, 343-353
35 Zhang L., Lau Y.K., Xi L., Hong R. L., Kim D. S., Chen C. F., Hortobagyi G. N., Chang C. and Hung M. C. (1998). Tyrosine kinase inhibitors, emodin and its derivative repress HER-2/neu-induced cellular transformation and metastasis-associated properties. Oncogene 4, 16, 2855-2863